183 related articles for article (PubMed ID: 10430890)
1. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH
J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595
[TBL] [Abstract][Full Text] [Related]
3. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
Takagi Y; Pause A; Conaway RC; Conaway JW
J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of elongin C from Saccharomyces cerevisiae.
Buchberger A; Howard MJ; Freund SM; Proctor M; Butler PJ; Fersht AR; Bycroft M
Biochemistry; 2000 Sep; 39(36):11137-46. PubMed ID: 10998253
[TBL] [Abstract][Full Text] [Related]
5. Identification of Elongin C and Skp1 sequences that determine Cullin selection.
Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW
J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393
[TBL] [Abstract][Full Text] [Related]
6. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
Stebbins CE; Kaelin WG; Pavletich NP
Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047
[TBL] [Abstract][Full Text] [Related]
7. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
8. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
Pause A; Lee S; Worrell RA; Chen DY; Burgess WH; Linehan WM; Klausner RD
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2156-61. PubMed ID: 9122164
[TBL] [Abstract][Full Text] [Related]
9. Characterization of elongin C functional domains required for interaction with elongin B and activation of elongin A.
Takagi Y; Conaway RC; Conaway JW
J Biol Chem; 1996 Oct; 271(41):25562-8. PubMed ID: 8810329
[TBL] [Abstract][Full Text] [Related]
10. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.
Kamura T; Koepp DM; Conrad MN; Skowyra D; Moreland RJ; Iliopoulos O; Lane WS; Kaelin WG; Elledge SJ; Conaway RC; Harper JW; Conaway JW
Science; 1999 Apr; 284(5414):657-61. PubMed ID: 10213691
[TBL] [Abstract][Full Text] [Related]
11. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR; Davidowitz EJ; Burk RD
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011
[TBL] [Abstract][Full Text] [Related]
12. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.
Kibel A; Iliopoulos O; DeCaprio JA; Kaelin WG
Science; 1995 Sep; 269(5229):1444-6. PubMed ID: 7660130
[TBL] [Abstract][Full Text] [Related]
13. The Hsp70 and TRiC/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex.
Melville MW; McClellan AJ; Meyer AS; Darveau A; Frydman J
Mol Cell Biol; 2003 May; 23(9):3141-51. PubMed ID: 12697815
[TBL] [Abstract][Full Text] [Related]
14. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC.
Feldman DE; Thulasiraman V; Ferreyra RG; Frydman J
Mol Cell; 1999 Dec; 4(6):1051-61. PubMed ID: 10635329
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.
Ohh M; Takagi Y; Aso T; Stebbins CE; Pavletich NP; Zbar B; Conaway RC; Conaway JW; Kaelin WG
J Clin Invest; 1999 Dec; 104(11):1583-91. PubMed ID: 10587522
[TBL] [Abstract][Full Text] [Related]
16. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
Hansen WJ; Ohh M; Moslehi J; Kondo K; Kaelin WG; Welch WJ
Mol Cell Biol; 2002 Mar; 22(6):1947-60. PubMed ID: 11865071
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transcription elongation by the VHL tumor suppressor protein.
Duan DR; Pause A; Burgess WH; Aso T; Chen DY; Garrett KP; Conaway RC; Conaway JW; Linehan WM; Klausner RD
Science; 1995 Sep; 269(5229):1402-6. PubMed ID: 7660122
[TBL] [Abstract][Full Text] [Related]
18. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.
Pause A; Peterson B; Schaffar G; Stearman R; Klausner RD
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9533-8. PubMed ID: 10449727
[TBL] [Abstract][Full Text] [Related]
19. The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.
Aso T; Haque D; Barstead RJ; Conaway RC; Conaway JW
EMBO J; 1996 Oct; 15(20):5557-66. PubMed ID: 8896449
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product.
Tsuchiya H; Iseda T; Hino O
Cancer Res; 1996 Jul; 56(13):2881-5. PubMed ID: 8674032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
